Ongoing low-dose maintenance (experimental) Continuous dosing approach: Dose: 1-2mg daily OR 3-5mg 2-3x weekly Duration: Ongoing (not cycled) Goal: Maintain constant telomerase activation Status: Experimental, not from research protocols Rationale: Telomerase needs continuous activation to maintain telomere length Cyclic dosing may allow regression between cycles Low-dose continuous might provide stable benefits Similar to maintenance protocols for other peptides Continuous dosing options: Advantages of continuous: No "off" periods where benefits regress Potentially stronger cumulative anti-aging More like natural physiologic regulation Easier to stack with other peptides Disadvantages: Much higher annual cost ($1,800-3,600 vs $300-600) No long-term safety data Uncertain if better than cyclic approach Storage challenges (more reconstitution) Deviates from proven protocols Current recommendation: Stick with proven 10-day cycles for most users Consider continuous only if cyclic approach inadequate Start with standard protocol first Assess your individual response Consult with peptide-knowledgeable physician Use our peptide cycle planning guide to design your Epithalon protocol
Zippl AL, Seeber B, Wildt L (2021) Obesity and infertility: are hyperlipidemia and hyperinsulinemia the bad guys
Hormonal footprint documented Controlled human comparisons (for example, ghrelin vs GHRP-6 vs GHRP-2) showed GHRP-6 raises GH along with measurable ACTH, cortisol, and prolactin, separating it from the cleaner profile of ipamorelin
After adjusting for age, sex, WC, BMI, alcohol, smoking, diabetes, hypertension, dyslipidemia and metabolic syndrome, insulin resistance, transaminases, and Hba1c, the association remained statistically significant with LSM (B=0.952
If you are over the age of 50, the enzymes you need to metabolize and absorb vitamin B12 decrease, making injections an ideal way to achieve optimal levels
Its broad regenerative profile makes it a prominent compound in models involving cellular repair, gastrointestinal integrity, and soft-tissue recovery
